Benitec Biopharma
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3940 Trust Way, Hayward, California, 945...Phone Number
(510) 780-0634Website
www.benitec.comRevenue
-Stock Symbol
BNTCIndustry
About Benitec Biopharma
Benitec Biopharma Inc. is a clinical-stage biotechnology company headquartered in Hayward, California, focused on the advancement of novel genetic medicines. The company's proprietary "Silence and Replace" platform combines DNA-directed RNA interference (ddRNAi) with gene therapy to create treatments that facilitate sustained silencing of disease-causing genes while simultaneously delivering wildtype replacement genes following a single administration. Benitec's lead program, BB-301, targets oculopharyngeal muscular dystrophy (OPMD) and has received Orphan Drug and Fast Track designations from the FDA as well as Orphan Drug Designation from the European Medicines Agency. The company's stock trades on the Nasdaq Stock Market under the ticker BNTC.Explore more
Benitec Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Benitec Biopharma
Compare insights from companies similar to Benitec Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Benitec Biopharma Tech Stack
A closer look at the technologies used by Benitec Biopharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Benitec Biopharma
Sign Up For FreeTo access detailed company insights
Benitec Biopharma Inc. is a clinical-stage biotechnology company headquartered in Hayward, California, focused on the advancement of novel genetic medicines. The company's proprietary "Silence and Replace" platform combines DNA-directed RNA interference (ddRNAi) with gene therapy to create treatments that facilitate sustained silencing of disease-c... Read More
